Trial reportClinical rheumatology2026
Predictors of 3-month response to US-guided sacroiliac joint injection: a prospective study of diagnostic block-confirmed patients.
Trial report in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06684938 (Predictors of Outcome for Sacroiliac Joint Injection With Local Anaesthetic and Corticosteroids in Sacroiliac Joint Pain Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Predictors of Outcome for Sacroiliac Joint Injection With Local Anaesthetic and Corticosteroids in Sacroiliac Joint Pain Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSacroiliac joint (SIJ) pain is a prevalent yet underappreciated source of LBP, with multiple etiologies and therapeutic options. Failure of the conservative approach necessitates interventional injections, especially with sonographic guidance to ensure precision of needle placement.
methodsOne hundred patients with isolated moderate SIJ pain were injected anesthetic and steroids with US guidance after failure of conservative measures. Those who attained immediate pain improvement > 50% were prospectively followed up for 3 months to determine the true responders and depict different patients' characteristics predicting this response.
resultsIn the univariate analysis manual work, high BMI, pain referred below the knee, and pre-injection MODQ were statistically significant predictors of failed pain improvement, whereas BMI and pre-injection MODQ were statistically significant predictors of failed function improvement. After multivariate analysis, obesity and pain referral below the knee were statistically significant predictors of failure of pain improvement. Successful pain and function improvement was significantly predicted by immediate post-injection improvement in VAS ≥ 80%.
conclusionsIndividualized treatment plans are essential based on patients' characteristics rather than symptoms and pathology.
trial registrationClinicalTrials.gov Identifier: NCT06684938/11 November 2024. Key Points • Patients with sacroiliac pain radiating below the knees were less likely to respond to sacroiliac joint injection. • Obese patients with sacroiliac pain were more likely to experience recurrence of their symptoms after SIJ injection.
Indexed as
Identifiers
42243610What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.